BathophenanthrolineCAS# 1662-01-7 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 1662-01-7 | SDF | Download SDF |
| PubChem ID | 72812 | Appearance | Powder |
| Formula | C24H16N2 | M.Wt | 332.4 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Solubility | DMSO : 6 mg/mL (18.05 mM; Need ultrasonic and warming); | ||
| Chemical Name | 4,7-diphenyl-1,10-phenanthroline | ||
| SMILES | C1=CC=C(C=C1)C2=C3C=CC4=C(C=CN=C4C3=NC=C2)C5=CC=CC=C5 | ||
| Standard InChIKey | DHDHJYNTEFLIHY-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C24H16N2/c1-3-7-17(8-4-1)19-13-15-25-23-21(19)11-12-22-20(14-16-26-24(22)23)18-9-5-2-6-10-18/h1-16H | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Bathophenanthroline Dilution Calculator
Bathophenanthroline Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 3.0084 mL | 15.0421 mL | 30.0842 mL | 60.1685 mL | 75.2106 mL |
| 5 mM | 0.6017 mL | 3.0084 mL | 6.0168 mL | 12.0337 mL | 15.0421 mL |
| 10 mM | 0.3008 mL | 1.5042 mL | 3.0084 mL | 6.0168 mL | 7.5211 mL |
| 50 mM | 0.0602 mL | 0.3008 mL | 0.6017 mL | 1.2034 mL | 1.5042 mL |
| 100 mM | 0.0301 mL | 0.1504 mL | 0.3008 mL | 0.6017 mL | 0.7521 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Bathophenanthroline is an agent used for the measurement of iron concentrations in aqueous , serum and urine samples by colorimetry.
- CCT251545
Catalog No.:BCC6487
CAS No.:1661839-45-7
- Ginkgolic acid C15:0
Catalog No.:BCN2483
CAS No.:16611-84-0
- 3,4-O-dimethylcedrusin
Catalog No.:BCN8211
CAS No.:166021-14-3
- Cyclogrifolin
Catalog No.:BCN7547
CAS No.:1660156-04-6
- Z-Thr-OBzl
Catalog No.:BCC2737
CAS No.:16597-50-5
- (-)-Tetramisole
Catalog No.:BCC4670
CAS No.:16595-80-5
- Calystegine A5
Catalog No.:BCN1887
CAS No.:165905-26-0
- Naltrexone
Catalog No.:BCC1783
CAS No.:16590-41-3
- 1-Hydroxy-N-methylacridone
Catalog No.:BCN7551
CAS No.:16584-54-6
- Eperezolid
Catalog No.:BCC5177
CAS No.:165800-04-4
- Linezolid
Catalog No.:BCC2496
CAS No.:165800-03-3
- Torososide A
Catalog No.:BCN4694
CAS No.:165689-32-7
- Argentinine
Catalog No.:BCN3987
CAS No.:16625-57-3
- Taberdivarine H
Catalog No.:BCN6958
CAS No.:1662688-34-7
- 9-O-Feruloyl-5,5'-dimethoxylariciresinol
Catalog No.:BCN1535
CAS No.:166322-14-1
- m-Nitrohydrocinnamic acid
Catalog No.:BCC9048
CAS No.:1664-57-9
- 1H-Pyrido[3,4-b]indole-1,3 4(2H,9H)-trione
Catalog No.:BCN7913
CAS No.:16641-79-5
- p-Nitrohydrocinnamic acid
Catalog No.:BCC9124
CAS No.:16642-79-8
- trans-4-(Trifluoromethyl)cinnamic acid
Catalog No.:BCN1534
CAS No.:16642-92-5
- Metaxalone
Catalog No.:BCC5223
CAS No.:1665-48-1
- Avasimibe
Catalog No.:BCC2274
CAS No.:166518-60-1
- H-Tyr(Bzl)-OH
Catalog No.:BCC3130
CAS No.:16652-64-5
- H-Pro-OBzl.HCl
Catalog No.:BCC3021
CAS No.:16652-71-4
- H-Val-OBzl.TosOH
Catalog No.:BCC3140
CAS No.:16652-76-9
Half-Sandwich Ru(II) and Os(II) Bathophenanthroline Complexes Containing a Releasable Dichloroacetato Ligand.[Pubmed:29443934]
Molecules. 2018 Feb 14;23(2). pii: molecules23020420.
We report on the preparation and thorough characterization of cytotoxic half-sandwich complexes [Ru(eta(6)-pcym)(bphen)(dca)]PF(6) (Ru-dca) and [Os(eta(6)-pcym)(bphen)(dca)]PF(6) (Os-dca) containing dichloroacetate(1-) (dca) as the releasable O-donor ligand bearing its own cytotoxicity; pcym = 1-methyl-4-(propan-2-yl)benzene (p-cymene), bphen = 4,7-diphenyl-1,10-phenanthroline (Bathophenanthroline). Complexes Ru-dca and Os-dca hydrolyzed in the water-containing media, which led to the dca ligand release (supported by (1)H NMR and electrospray ionization mass spectra). Mass spectrometry studies revealed that complexes Ru-dca and Os-dca do not interact covalently with the model proteins cytochrome c and lysozyme. Both complexes exhibited slightly higher in vitro cytotoxicity (IC50 = 3.5 muM for Ru-dca, and 2.6 muM for Os-dca) against the A2780 human ovarian carcinoma cells than cisplatin (IC50 = 5.9 muM), while their toxicity on the healthy human hepatocytes was found to be IC50 = 19.1 muM for Ru-dca and IC50 = 19.7 muM for Os-dca. Despite comparable cytotoxicity of complexes Ru-dca and Os-dca, both the complexes modified the cell cycle, mitochondrial membrane potential, and mitochondrial cytochrome c release by a different way, as revealed by flow cytometry experiments. The obtained results point out the different mechanisms of action between the complexes.
